The safety of temozolomide in the treatment of malignancies

Author： Trinh Van Anh Patel Sapna Pradyuman Hwu Wen-Jen

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.4, 2009-07, pp. : 493-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy and safety of ixabepilone monotherapy in the treatment of breast and gynecologic malignancies

By Gupta Divya Mani Sridhar

Expert Opinion on Drug Safety, Vol. 8, Iss. 1, 2009-01 ,pp. : 81-88

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of the Combination of Docetaxel (Taxotere#174;) with Targeted Therapies in the Treatment of Solid Malignancies

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 982-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

Immunotoxins in the Treatment of Hematologic Malignancies

Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. : 1301-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Temozolomide

By Hvizdos K.M. Goa K.L.

CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. : 237-243

Adis International

Access to resources Recommend Favorite